Stay updated on XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial
Sign up to get notified when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.

Latest updates to the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No user-facing content appears to be altered, including study details or results.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page; no substantive content changes.SummaryDifference0.1%

- Check33 days agoChange DetectedThe updates are minor UI and metadata adjustments, including glossary toggle options, capitalization changes in the footer text, and a new revision version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedThe page shows a minor revision tag update from v3.3.3 to v3.3.4 that does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded a Locations section with Missouri as a site, and removed the Missouri Locations entry. The document revision was updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedPublications section text now states that publications are automatically filled from PubMed, and the Revision tag has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.